LifeMD (LFMDP) Cost of Revenue (2012 - 2025)

LifeMD has reported Cost of Revenue for 14 years, with the latest figure at -$12.4 million in Q4 2025.

• For the quarter ending Q4 2025, Cost of Revenue fell 630.11% year-over-year to -$12.4 million; the trailing twelve-month figure through Dec 2025 stood at $22.9 million (up 64.87% YoY), and the FY2025 full-year result was $11.1 million, up 27.87% from the prior year.
• Cost of Revenue for Q4 2025 stood at -$12.4 million, down from $3.0 million in the prior quarter.
• The five-year high for Cost of Revenue was $71.8 million in Q4 2023, with the low at -$57.9 million in Q4 2021.
• Historically, Cost of Revenue has averaged $5.4 million across 5 years, with a median of $4.6 million in 2022.
• The largest YoY upside for Cost of Revenue was 1293.54% in 2021 against a maximum downside of 13834.51% in 2021.
• LifeMD's Cost of Revenue stood at -$57.9 million in 2021, then rose by 6.4% to -$54.2 million in 2022, then surged by 232.47% to $71.8 million in 2023, then plunged by 96.74% to $2.3 million in 2024, then plunged by 630.11% to -$12.4 million in 2025.
• The last three Cost of Revenue figures came in at -$12.4 million (Q4 2025), $3.0 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.